Xenografted human amniotic fluid-derived stem cell as a cell source in therapeutic angiogenesis.

[1]  F. Milliat,et al.  Plasminogen Activator Inhibitor‐1 Controls Bone Marrow‐Derived Cells Therapeutic Effect Through MMP9 Signaling: Role in Physiological and Pathological Wound Healing , 2012, Stem cells.

[2]  M. Ashraf,et al.  Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9. , 2012, Stem cells and development.

[3]  C. Kim,et al.  Amniotic mesenchymal stem cells have robust angiogenic properties and are effective in treating hindlimb ischaemia. , 2012, Cardiovascular research.

[4]  Prof. Dr. med. Gustav Steinhoff,et al.  Cardiac stem cell therapy , 2011, Herz.

[5]  A. Coats,et al.  Ethics in the authorship and publishing of scientific articles , 2010 .

[6]  M. Tsai,et al.  Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model. , 2010, Biomaterials.

[7]  R. Kloner,et al.  Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. , 2009, Journal of the American College of Cardiology.

[8]  A. Freilinger,et al.  Human amniotic fluid stem cells: a new perspective , 2008, Amino Acids.

[9]  Richard T. Lee,et al.  Stem-cell therapy for cardiac disease , 2008, Nature.

[10]  Jae Min Lim,et al.  Improvement of Postnatal Neovascularization by Human Embryonic Stem Cell–Derived Endothelial-Like Cell Transplantation in a Mouse Model of Hindlimb Ischemia , 2007, Circulation.

[11]  Hyunjin Cho,et al.  Direct Comparison of Human Mesenchymal Stem Cells Derived from Adipose Tissues and Bone Marrow in Mediating Neovascularization in Response to Vascular Ischemia , 2007, Cellular Physiology and Biochemistry.

[12]  P. Wiedemann,et al.  Positive feedback regulation between MMP-9 and VEGF in human RPE cells. , 2007, Investigative ophthalmology & visual science.

[13]  G. Zucconi,et al.  Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain , 2007, Cell biology international.

[14]  Anthony Atala,et al.  Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.

[15]  A. Angelini,et al.  Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. , 2007, Journal of molecular and cellular cardiology.

[16]  T. Hampton.  Stem cells obtained from amniotic fluid. , 2007, JAMA.

[17]  H. Kim,et al.  Human amniotic fluid‐derived stem cells have characteristics of multipotent stem cells , 2007, Cell proliferation.

[18]  C. Holden.  Versatile Stem Cells Without the Ethical Baggage? , 2007, Science.

[19]  R. Dickson,et al.  Matriptase activates stromelysin (MMP‐3) and promotes tumor growth and angiogenesis , 2006, Cancer science.

[20]  Richard T. Lee,et al.  Local Controlled Intramyocardial Delivery of Platelet-Derived Growth Factor Improves Postinfarction Ventricular Function Without Pulmonary Toxicity , 2006, Circulation.

[21]  Joshua M. Hare,et al.  Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step . , 2006, Circulation.

[22]  P. Oettgen,et al.  Stem Cell Therapy : Need for Optimization of Efficacy and Safety Monitoring , 2006 .

[23]  S. Verma,et al.  Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. , 2006, The Journal of clinical investigation.

[24]  Hoon Han,et al.  Successful Stem Cell Therapy Using Umbilical Cord Blood‐Derived Multipotent Stem Cells for Buerger's Disease and Ischemic Limb Disease Animal Model , 2006, Stem cells.

[25]  Richard T. Lee,et al.  Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. , 2005, The Journal of clinical investigation.

[26]  C. Murry,et al.  Regenerating the heart , 2005, Nature Biotechnology.

[27]  Nan Ma,et al.  Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. , 2005, Cardiovascular research.

[28]  A. Zeiher,et al.  Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? , 2004, Journal of Molecular Medicine.

[29]  M. Tsai,et al.  Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. , 2004, Human reproduction.

[30]  S. Rafii,et al.  Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment , 2002, Nature Medicine.

[31]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[32]  Eric Johnson,et al.  Developmental Control of Blood Cell Migration by the Drosophila VEGF Pathway , 2002, Cell.

[33]  K. Ouriel.  Peripheral arterial disease , 2001, The Lancet.

[34]  K. Bayne.  Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. , 1996, The Physiologist.

[35]  E. Engvall,et al.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. , 1972, Journal of immunology.

[36]  C. W. Greene.  THE AMERICAN PHYSIOLOGICAL SOCIETY. , 1922, Science.

[37]  W. Liao,et al.  The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan. , 2011, Biomaterials.

[38]  F. Cogé,et al.  The role of the matrix metalloproteinases during in vitro vessel formation , 2004, Angiogenesis.